[1] ROMERO JR,WOLF PA.Epidemiology of stroke:legacy of the framingham heart study[J].Clob Heart,2013,8(1):67.
[2] SANDHU RK,MC ALISTER FA.Stroke prevention for patients with atrial fibrillation:improving but not perfect yet[J].Heart,doi:10.1136/heartjhl-2013-303656.
[3] 郭秀芳.波立维联合拜阿斯匹林治疗颈内动脉系统进展性脑梗死的临床观察[J].河北医药,2013,35(8):1161.
[4] 陆再应,钟南山.内科学[M].7版.北京:人民卫生出版社,2008.
[5] 马莉,张苏明.进展性脑卒中的研究进展[J].卒中与神经疾病,2006,13(3):190.
[6] BOTS ML,HOES AW,KOUDSTAAL PJ,et al.Common carotid intima-media thickness and risk of stroke and myocardial infarction:the Rotterdam Study[J].Circulation,1997,91(5):1432.
[7] CHAMBLESS LE,FOLSOM A,CLEGG LX,et al.Carotid wall thickness is predictive of incident clinical stroke:the Atherosclerosis Risk in Communities(ARIC) study[J].Am J Epidemiol,2000,151(5):478.
[8] 王玮.进展性脑卒中危险因素的临床分析[J].中国老年学杂志,2013,33(23):5811.
[9] CHEN GJ,YANG MS.The effects of calcium channel blockers in the prevention of stroke in adult with hypertension:a meta-analysis of data from 273,543 participants in 31 randomized controlled trials[J].PloS One,2013,8(3):e57854.
[10] 胡文海.氯吡格雷联合肠溶阿司匹林治疗进展性脑梗死的疗效观察[J].蚌埠医学院学报,2014,39(5):633.
[11] 向平.氯吡格雷联合阿司匹林治疗进展性脑卒中的临床效果观察[J].现代诊断与治疗,2012,23(8):1278.